Abstract
Technetium99m (99mTc) Scintigraphy is a well established tool for diagnosing Thyroid disease. The purpose of this study is to evaluate the usage of this particular method in detecting residual thyroid disease after surgery and its role as a diagnostic marker for the work up of a patient with residual disease. All were female patients seen in the ENT OPD for a period of 1 year from Feb 2004–Jan 2005, within the age group 24 yrs to 50 yrs.
Key words: 99mTc, Thyroidectomy, I-131, Residual thyroid disease
Full Text
The Full Text of this article is available as a PDF (482.7 KB).
Footnotes
An erratum to this article is available at http://dx.doi.org/10.1007/BF03049591.
References
- 1.Meier DA, Kaplan MM. Radioiodine uptake & thyroid scintiscanning. Endocrinol Metab clinic of North Am. 2001;30(2):291–313. doi: 10.1016/S0889-8529(05)70188-2. [DOI] [PubMed] [Google Scholar]
- 2.Douglas IR, Cavalieu RR. In vivo radionucletide test and imaging. In: Braverman LE, Utiger RD, editors. Editors The thyroid. 8th edition. Philadelphia: Lipincott Williams & Wilkins; 2000. pp. 355–75. [Google Scholar]
- 3.Castro MR, Gharib H. Thyroid nodules and cancer: when to wait and watch, when to refer. Postgrad Med. 2000;107(1):113–24. doi: 10.3810/pgm.2000.01.808. [DOI] [PubMed] [Google Scholar]
- 4.Meyer G, Kleine V, Lommatzsch B. Comparison of I-131 & Tc 99m Sestamibi whole body scans in the follow up of differentiated thyroid carcinoma. J Nucl Med. 1995;36:200P–200P. [Google Scholar]
- 5.Ramanna L, Waxman A, Braunstein G. Thallium — 201 scintigraphy in differentiated thyroid cancer: Comparison with radioiodine Scintigraphy & serum thyroglobulin determination. J Nucl Med. 1991;32:441–441. [PubMed] [Google Scholar]
- 6.Roga G, Fiorentino A, Paserio E, et al. can Iodine-131 whole body scan be replaced by thyroglobulin measurement in the post surgical follow up of differentiated thyroid carcinoma. J Nucl Med. 1990;31:1766–1766. [PubMed] [Google Scholar]
- 7.Pacini F, Lippi F, Formica N, et al. therapeutic doses of iodine-131 reveal undiagnosed metastasis in thyroid cancer patients with detectable serum thyroglobulin level. J Nucl Med. 1987;28:1888–1888. [PubMed] [Google Scholar]